Replies to post #107697 on Progressive Care Inc (fka RXMD)

[stockforce]

$18M acquisition to be completed by Jan. 15; CBD partnership and production to be announced in January; $21M+ revenue for 2018; $40M revenue after acquisition; $45 - 50M revenue for 2019 with new CBD business, Telepharmacy, expanded 340B, more acquisitions and more out-of-state licenses; 3rd year audit by March; fully SEC reporting by March; NASDAQ by 2020, probably in late 2019!

[straighttalk2004]

Thanks and well laid out Spider Web. Good info for newbies considering an investment in 2019. The slide countinues in 2019 until the stock settles into “fair value” range ($10-$15M valuation).